Pre-Grant Opposition | Intellepedia

Abbott’s HIV Drug Patent “Not an Invention”

The Indian Patent Office has rejected Abbott’s application for an HIV drug patent, finding no inventive step in the claimed composition. This decision highlights the robust scrutiny applied to pharmaceutical patents in India and the importance of pre grant opposition in safeguarding public health interests.

Mock Opposition Proceedings – A mock problem by Dr. Kalyan C. Kankanala at UPES School of Law

This mock problem examines a patent opposition proceeding under Indian law, involving claims of wrongful obtainment and lack of inventive step. It highlights core issues faced in patent litigation and legal standing in opposition cases.

Pre Grant Opposition of Patents in India – Lecture by Dr. Kalyan C. Kankanala at UPES School of Law

Dr. Kalyan C. Kankanala discusses the pre grant opposition of patents in India, focusing on the legal provisions and grounds available under Section 25(1). The lecture highlights the importance of the opposition process in safeguarding patent quality.

Patent opposition system in India: Pre-grant & Post grant oppositions

The Indian patent opposition system offers structured processes for pre-grant and post grant challenges to patent validity. This post outlines the procedures, grounds, and key advantages of opposition proceedings under Indian patent law.

Patent Law-Basics of Patent Process- A PPT by Somashekar Ramakrishna at NLSIU

The following presentation was delivered by Mr. Somashekar Ramakrishna, Partner BananaIP Counsels, at National Law School of India University, Bangalore (NLSIU), as a part of...

Introduction to Pre-grant & Post-grant Oppositions to Patent Applications

This post provides an analytical overview of pre-grant and post-grant opposition provisions in Indian patent law. It explains the procedural and substantive changes introduced by the Patents (Amendment) Act, 2005.

Drug Humira turns Rheumatic for Abbott Biotechnology

The Indian Patent Office set aside Abbott Biotechnology’s Humira patent after Glenmark’s pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges to Humira patents both in India and globally.

Patent Opposition and Revocation: A Presentation

This post examines patent opposition and revocation procedures under Indian law, including pre-grant and post-grant processes. It analyses legal grounds and roles of authorities involved, providing insights through a structured legal perspective.